Skip to main content

Table 2 Estimates of prevalence of obesity among Iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

 

Obesity

Overweighta

 

National

estimateb

Prevalence

(95% CI)

National

estimateb

Prevalence

(95% CI)

Age

    

   25–34 (n = 1081)

1.8

14.4 (11.5–17.8)

4.1

31.8 (29.0–34.7)

   35–44 (n = 1113)

2.4

26.7 (22.7–31.1)

3.5

39.4 (36.1–42.8)

   45–54 (n = 1069)

1.8

29.3 (25.6–33.2)

2.5

39.8 (36.4–43.3)

   55–64 (n = 970)

0.9

27.4 (24.1–31.0)

1.3

39.3 (35.1–43.6)

Sex

    

   Males (n = 2121)

2.3

14.2 (12.2–16.5)

6.0

37.5 (35.0–40.1)

   Females (n = 2112)

4.7

30.6 (27.3–34.0)

5.4

35.1 (32.8–37.6)

Residential area

    

   Urban (n = 2853)

5.3

23.8 (21.5–26.2)

8.6

38.2 (36.2–40.2)

   Rural (n = 1380)

1.7

18.5 (14.5–23.4)

2.8

31.7 (28.4–35.3)

Total national estimate

(n = 4233)

7.0

22.3 (20.2–24.5)

11.4

36.3 (34.6–38.1)

  1. CI: confidence interval
  2. a In non-obese subjects
  3. b Rounded to the nearest million
  4. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006